Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINC00887 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PCNX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RGL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEPE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP53RK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RFX7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ICK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF12L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NT5C1B-RDH14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPHP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFLAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP2CB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930568 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD51L3-RFFL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRAF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on